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infection-mediated neurodevelopmental disorders
U Weber-Stadlbauer
Prenatal infection is an environmental risk factor for various brain disorders with neurodevelopmental components, including
autism spectrum disorder and schizophrenia. Modeling this association in animals shows that maternal immune activation
negatively affects fetal brain development and leads to the emergence of behavioral disturbances later in life. Recent discoveries in
these preclinical models suggest that epigenetic modiﬁcations may be a critical molecular mechanism by which prenatal immune
activation can mediate changes in brain development and functions, even across generations. This review discusses the potential
epigenetic mechanisms underlying the effects of prenatal infections, thereby highlighting how infection-mediated epigenetic
reprogramming may contribute to the transgenerational transmission of pathological traits. The identiﬁcation of epigenetic
and transgenerational mechanisms in infection-mediated neurodevelopmental disorders appears relevant to brain disorders
independently of existing diagnostic classiﬁcations and may help identifying complex patterns of transgenerational disease
transmission beyond genetic inheritance. The consideration of ancestral infectious histories may be of great clinical interest and
may be pivotal for developing new preventive treatment strategies against infection-mediated neurodevelopmental disorders.
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INTRODUCTION
Disruption of normal brain development is implicated in a number
of neuropsychiatric diseases with neurodevelopmental origins,
including schizophrenia, autism spectrum disorder and bipolar
disorder.1 One commonality between these disorders is that the
underlying pathological processes likely start early during fetal
development and continues during subsequent brain maturation.2
The disruption of neurodevelopmental and maturational pro-
cesses can lead to widespread and long-lasting abnormalities in
central nervous system structure and functions. Typically, neuro-
developmental disorders are characterized by a heterogeneous
group of symptoms affecting cognitive functions, emotions and
behavior, thereby undermining basic human processes of
perception and judgment. In view of their chronicity and severity,
neurodevelopmental disorders impose tremendous burdens on
the affected individuals, and in turn, on their families and society
in general.3
Besides genetic contributions,4 various environmental factors
appear to increase the risk for neurodevelopmental disorders.1,5
Many of these factors operate during critical periods of central
nervous system development. One of these factors is prenatal
exposure to infection, which is increasingly recognized to play an
important etiological role in various brain disorders with neuro-
developmental components, including schizophrenia,5,6 autism
spectrum disorder7,8 and bipolar disorder.6,9 Hence, prenatal
exposure to immune challenges may be best viewed as a general
vulnerability factor for neurodevelopmental brain disorders rather
than a disease-speciﬁc risk factor.10,11 Indeed, the adverse effects
induced by prenatal infection may reﬂect an early entry into a
deviant neurodevelopmental route, but the speciﬁcity of sub-
sequent disease or symptoms is likely to be inﬂuenced by the
genetic and environmental context in which the prenatal
infectious process occurs. This notion is consistent with the
emerging evidence suggesting that seemingly remote disorders,
such as schizophrenia, autism spectrum disorder and attention-
deﬁcit/hyperactivity disorder share considerable amounts of risk
factors and brain dysfunctions.10,11 The presence of shared genetic
and environmental risks among these illnesses has led to the
proposal that they might lie along a continuum of genetically and
environmentally induced neurodevelopmental causalities,1,12
wherein prenatal infection may be one of the many factors that
shape the eventual pathological outcomes.
The epidemiological link between prenatal infection and
increased risk of neurodevelopmental brain disorders also receives
strong support from experimental work in animal models.13 On
the basis of human epidemiological ﬁndings, a number of
translational rodent models have been established to explore
the consequences of prenatal immune activation on brain and
behavioral development. These models are based on maternal
gestational exposure to speciﬁc infectious agents such as
inﬂuenza virus or immune activating agents such as the bacterial
endotoxin lipopolysaccharide or the viral mimic poly(I:C) ( = poly-
riboinosinic–polyribocytidylic acid). Converging evidence from
these models suggests that prenatal immune activation can
negatively affect early fetal brain development and change the
offspring’s neurodevelopmental trajectories, which in turn can
lead to the emergence of behavioral and cognitive disturbances in
later life.13–16 The long-term behavioral and cognitive abnormal-
ities induced by prenatal immune challenges in rodent models
have already been extensively reviewed elsewhere (for review see
Meyer,13 Meyer and Feldon,15 and Estes and McAllister17) and
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have recently been extended to models using primates with more
advanced cortical development and functions.18–20
Despite the advances in this research ﬁeld, the mechanisms
whereby prenatal infection leads to long-term effects on central
nervous system functions are only partially understood. In keeping
with the crucial role of epigenetic remodeling in early develop-
ment, it has recently been postulated that epigenetic modiﬁca-
tions may be a critical molecular mechanism by which prenatal
immune activation can mediate changes in brain development
and functions.21,22 The present review summarizes and integrates
novel ﬁndings supporting this hypothesis and highlights how
infection-mediated epigenetic reprogramming could be a mole-
cular mechanism shaping disease risk across generations.
PATHOPHYSIOLOGICAL PROCESSES INDUCED BY MATERNAL
INFECTION
Infection during pregnancy induces a spectrum of pathophysio-
logical changes in the maternal host and fetal compartments.23
Figure 1 provides a schematic summary of the most relevant
pathophysiological processes associated with maternal infection
during pregnancy. The nature of these processes, and the
resulting neurodevelopmental sequelae in the offspring, are likely
inﬂuenced by a number of factors, including virulence of the
pathogen, timing of infection and (genetic) susceptibility of the
host. Interestingly, increased risk for neurodevelopmental dis-
orders is observed following prenatal exposure to a variety of
pathogens, including inﬂuenza, rubella, measles, polio and others
(for review see Brown and Derkits,5 and Silasi et al.23). Only some
of these pathogens are vertically transmitted and directly invade
the fetal system. One prominent example showing transplacental
transmission is rubella, which has long been known to be res-
ponsible for a spectrum of developmental abnormalities referred
to as the congenital rubella syndrome.24 The majority of
pathogens, however, stay reﬁned to the maternal host upon
infection during pregnancy.23 Even when lacking vertical trans-
mission, maternal infection during pregnancy can induce long-
term effects on the offspring, suggesting that the association
between prenatal infection and neurodevelopmental disorders is,
to a large extent, driven by factors that are common to all
infections. In support of this notion, rodent studies provide sub-
stantial evidence for the hypothesis that inﬂammatory cytokines
are one of the key players in re-wiring ongoing developmental
processes into pathological trajectories following prenatal
infection.25–27 Cytokines are increased during the acute phase
response to infection and are important mediators of the host’s
defense against infectious agents.28,29 In the context of prenatal
infection, some of the maternally produced cytokines can be
transferred via the placenta, as shown in animals and human
placental tissue,30,31 and contribute to cytokine imbalances in
the fetal system. In addition, the placenta and fetal organs can
mount increased cytokine production in response to maternal
infection.32–34
The post-acute effects of maternal infections are not limited to
cytokine-associated inﬂammatory responses but further involve
other pathophysiological processes, including nutrient deﬁciency
and oxidative stress (Figure 1). Oxidative stress refers to an
increase in production and/or decrease in elimination of reactive
oxygen species. Reactive oxygen species are released as part of
an activation cascade of innate immune cells to kill invading
pathogens35 and can exert cytotoxic effects. Similar to cytokines,
reactive oxygen species levels typically rise in response to an
Figure 1. Post-acute pathophysiological effects of maternal infection during pregnancy. Some infectious pathogens (for example, rubella virus,
cytomegalovirus, herpes simplex virus-2 and Toxoplasma gondii) can be vertically transmitted and lead to congenital infections, which in turn
can result in severe developmental deﬁcits. Maternal infection during pregnancy can further induce a number of pathophysiological
responses, even if the pathogen is not vertically transmitted. These responses include the production of soluble immune factors such as
cytokines and other mediators of inﬂammation, as well as reactive oxygen species. Some of these factors might cross the placental barrier and
enter the fetal environment, thereby causing fetal inﬂammation and oxidative stress. Maternal infection during pregnancy can further induce
inﬂammatory response in the placenta and cause placental insufﬁciency, which in turn can cause fetal hypoxemia. In addition, infection can
cause (temporary) states of macronutrient and micronutrient deﬁciency, which limits the fetal availability of essential nutrients necessary for
normal fetal development and growth. Finally, maternal infection during pregnancy can modify the microbial composition of the placenta,
which might alter the development of the offspring’s microbiome (not shown).
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infection, which in turn can trigger oxidative stress in the fetal
environment and negatively affect fetal brain development, both
in humans and in animal models.36
Reduced availability of macro- and micronutrients for the fetus
is yet another important post-acute effect of maternal infection
(Figure 1). The infected host usually displays signs of sickness
behavior, which is characterized by fever, malaise and reduced
water and food intake.37 Reduction in food intake might indeed
be of great relevance in the context of prenatal infection, with
several studies highlighting a signiﬁcant link between prenatal
malnutrition and pathological brain development.38,39 Studies in
rats and mice suggest that the association between prenatal
malnutrition and neurodevelopmental disorders might result, at
least in part, from a reduction in the availability of micronutrients
such as zinc and iron, which are crucial for normal brain
development.40,41
Finally, it should be noted that infection-induced pathophysio-
logical changes in the placenta might amplify the response to
maternal infection and the downstream pathological effects on
the fetus. The placenta plays a key role in maternal–fetal
interactions and expresses a variety of factors important for the
homeostatic response to infectious agents.42 Maternal infections
also typically disrupt the circulation and architecture of the
placenta,27,43,44 as shown by studies in rodents and humans,
which in turn can induce placental insufﬁciency and reduce the
delivery of oxygen and essential nutrients to the developing
offspring (Figure 1).
In summary, infection during pregnancy induces a number of
post-acute pathophysiological processes in the maternal host,
which in turn can all contribute to the disruption of normal brain
development. As discussed in detail below, novel ﬁndings suggest
that epigenetic modiﬁcations may represent an important
molecular mechanism whereby these post-acute pathophysiolo-
gical processes are translated into long-term brain abnormalities,
even across generations.
A NOVEL ROLE OF EPIGENETIC MODIFICATIONS IN INFECTION-
MEDIATED NEURODEVELOPMENTAL DISORDERS
A short overview of epigenetic mechanisms
‘Epigenetics’ refers to the combination of mechanisms that confer
long-term and heritable changes in gene expression without
altering the DNA sequence itself.21 Epigenetic programming is
dynamic and responsive to different environmental exposures
during development and includes several interrelated processes
(Figure 2), including chromatin remodeling, histone modiﬁcations,
DNA methylation and expression of microRNAs (miRNAs).21,22,45
Histone modiﬁcations are covalent post-translational modiﬁcations
of histone proteins, which include, among others, methylation,
phosphorylation, acetylation, ubiquitylation and sumoylation.21,22,45
Histone modiﬁcations can deﬁne the extent to which DNA is
wrapped around the nucleosome core, thereby inﬂuencing the
accessibility of the gene transcription machinery and subsequent
gene expression. DNA methylation, on the other hand, consists of
covalent methylation of cytosine rings that are found at cytosine–
phosphodiester–guanine (CpG) dinucleotides.21,22,45 When located
in distinct genomic regions such as gene promoter or enhancer
sites, DNA methylation typically acts to repress gene transcrip-
tion.21,22,45 Silencing of gene transcription by DNA methylation
can be mediated by direct interference with the binding of
transcription factors or enhancers to recognition elements that
contain CpG dinucleotides, or through recruitment of methylated
DNA-binding factors that in turn attract chromatin-inactivating
complexes including histone deacetylases and histone methyl-
transferases. Finally, miRNAs are a class of small non-encoding
RNAs (~22 nucleotides long) that can control target gene
expression post-transcriptionally.21,22,45 Interestingly, recent
studies have demonstrated that epigenetic mechanisms, such as
DNA methylation, not only regulate the transcription of protein-
encoding genes, but also the expression of miRNAs.46 Conversely,
miRNAs can control the expression of important epigenetic
regulators, including DNA methyltransferases and histone deace-
tylases. Hence, there is a dynamic regulatory network between
different epigenetic pathways, which altogether organize gene
expression proﬁles through transcriptional or post-transcriptional
mechanisms.21,22,45,46
How can epigenetic modiﬁcations inﬂuence brain development?
A growing number of studies highlight the importance of
epigenetic mechanisms in normal brain development.45 Interest-
ingly, transcriptional changes in the brain occur more frequently
during prenatal life as compared to any other age in life.47 A
temporally precise and speciﬁc regulation of gene expression thus
seems indispensable for normal brain development. This regula-
tory process involves methylation-related epigenetic modiﬁca-
tions, which allow a ﬁne-tuning of fetal gene expression according
to speciﬁc stages of brain development.48–50 A critical role for DNA
methylation in early brain development is also supported by the
dynamic expression of DNA methyltransferases during prenatal
life,51 and by studies using transgenic mouse models showing
neurodevelopmental deﬁcits in mice with mutations in the
methyl-CpG-binding protein 2 (Mecp2) gene.52,53 Furthermore,
mice lacking distinct DNA methyltransferases (DNMTs) in the
forebrain have been found to display severe learning and memory
deﬁcits, as well as impaired synaptic plasticity.54,55
In addition to epigenetic processes involving DNA methylation,
several other epigenetic mechanisms appear to be critical for
Figure 2. Schematic representation of major epigenetic mechan-
isms. The DNA–protein complex is referred to as chromatin. The
functional unit of the chromatin is the nucleosome, which is
composed of DNA wrapped around a core octamer of histone
proteins. The DNA–histone interaction occurs at the N-terminal tails
of these histones, which face outward and are sites for epigenetic
marking known as histone modiﬁcations. These modiﬁcations
represent a ﬁrst major epigenetic mechanism modulating gene
expression and involve methylation, phosphorylation, acetylation,
ubiquitylation and sumoylation. DNA methylations at cytosine rings,
typically found at CpG dinucleotides, are another important
epigenetic mark that can inﬂuence gene expression. Finally, micro-
RNAs (miRNAs), a class of small, non-coding RNAs, can control target
gene expression post-transcriptionally. CpG, cytosine–phosphodie-
ster–guanine.
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neuronal development and functions. For example, it has been
shown that histone modiﬁcations can regulate the conversion of
oligodendrocytes into neural stem cells.56 Furthermore, Fischer
et al.57 demonstrated in a mouse model of neurodegenerative
disorders that increasing histone acetylation could promote
synaptogenesis and augment cognitive functions.
Accumulating evidence suggests that miRNAs may similarly
play a role in central nervous system development. For example, it
has been shown that miRNAs in speciﬁc neuronal or glial cell
populations show a dynamic expression pattern during brain
development.58,59 Moreover, a recent study reported distinct
temporal patterns of miRNA expression in the brain throughout
gestation, and from early neonatal to adult life.60 The devel-
opmentally regulated pattern of miRNA expression is indicative of
a functional role of these molecules in normal brain development.
However, our understanding of how miRNA can inﬂuence
neurodevelopmental processes is still in its infancy and warrants
further investigations.
The importance of epigenetic mechanisms in brain develop-
ment is also supported by a plethora of ﬁndings demonstrating
epigenetic alterations in neurodevelopmental disease models that
are based on exposure to environmental adversities in early life. As
reviewed in detail elsewhere21,45,61 stable epigenetic modiﬁca-
tions may represent an important mechanism by which exposures
to early-life environmental adversities can induce pathological
consequences, even across multiple generations. Transgenerational
transmission of disease susceptibility or epigenetic modiﬁcation
has been observed following early-life exposure to various
environmental adversities (see Table 1 for prenatal environmental
adversities), including prenatal or neonatal stress,62–69 prenatal
malnutrition,70–75 endocrine disruptors76–81 and chronic psychos-
timulant or alcohol intake.82,83 The phenomenon of non-genetic
transgenerational transmission of behavioral traits has gained
increasing recognition in view of its potential importance in the
etiology and treatment of multifactorial disorders.61,84,85 As
discussed in the subsequent sections, recent research now
suggests that similar effects can be induced by prenatal exposure
to infection.
EPIGENETIC AND TRANSGENERATIONAL EFFECTS OF
PRENATAL INFECTION
Epigenetic modiﬁcations induced by prenatal infection
Several recent studies sought to examine the putative effects of
prenatal infection on epigenetic processes. Using a rat model of
poly(I:C)-induced maternal immune activation, Hollins et al.86
revealed that prenatally infected offspring exhibited signiﬁcant
differences in the expression of miRNA in the entorhinal cortex, a
brain area implicated in neurodevelopmental disorders. Interest-
ingly, a large subset of these miRNAs were clustered within the
Dlk1-Dio3-imprinted domain on 6q32, which is associated with
schizophrenia, and were predicted to regulate pathways involved
in synaptic remodeling, learning and memory formation.86
Maternal immune activation by poly(I:C) treatment in mice has
also been found to alter histone modiﬁcations in the offspring.
More speciﬁcally, offspring of poly(I:C)-treated mice displayed
changes in promoter-speciﬁc histone acetylation and correspond-
ing transcriptional changes, the latter of which affected genes
associated with neuronal development, synaptic transmission and
immune signaling.87
Accumulating evidence suggest that prenatal infection can also
cause stable changes in DNA methylation. For example, Basil
et al.88 found that prenatal exposure to the viral mimic poly(I:C)
caused global changes in the level of DNA methylation in the
adolescent mouse brain, including Mecp2 promoter hypomethy-
lation. A recent study by Labouesse et al.89 extended those
ﬁndings by assessing correlations between DNA-related T
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epigenetic modiﬁcations, expression levels of corresponding
genes and behavioral deﬁcits. The authors showed that prenatal
viral-like immune activation by poly(I:C) in mice induced
methylation-related promoter remodeling of GAD1 and GAD2 in
the prefrontal cortex. GAD1 and GAD2 encode for two isoforms of
the rate-limiting enzyme for γ-aminobutyric acid biosynthesis. It
was shown that offspring born to immune-challenged mothers
displayed GAD1 and GAD2 promoter hypermethylation and
associated reductions in the expression of the corresponding
mRNA transcripts (GAD67 and GAD65), which in turn correlated
with deﬁcits in social interaction and impairments in working
memory.89 These ﬁndings suggest that methylation-related
epigenetic modiﬁcations at presynaptic GABAergic systems may
represent a mechanism whereby maternal infection during
pregnancy can induce long-term behavioral impairments in the
offspring.
Using the same mouse model of poly(I:C)-induced maternal
immune activation, a recent study by Richetto et al.90 examined
genome-wide DNA methylation differences at single-nucleotide
resolution by capture array bisulﬁte sequencing in the adult
prefrontal cortex. It was shown that offspring of immune-
challenged mothers displayed hyper- and hypomethylated CpGs
at numerous loci and at distinct genomic regions.90 The
differences in methylation were again associated with transcrip-
tional changes of the corresponding genes, suggesting that the
infection-induced epigenetic modiﬁcations had a functional
impact on gene expression.90
Taken together, these ﬁndings indicate that prenatal infection
can cause lasting changes in the offspring’s epigenome. The
available data thus far show that viral-like maternal immune
activation in early/middle (between gestation day (GD) 9 and
12)87,88 or in late (GD15 and beyond)86,89 gestation causes such
changes. Recent evidence suggests, however, that the timing of
viral-like immune challenge critically determines the speciﬁcity of
infection-mediated epigenetic modiﬁcations,90 since early and late
gestational window clearly differ in terms of methylation-related
epigenetic modiﬁcations they induce.
Transgenerational effects of prenatal infection
Recent studies extended the abovementioned ﬁndings by
assessing whether behavioral and cognitive abnormalities emer-
ging in the direct descendants (F1) of gestationally immune-
challenged mothers could be transmitted across subsequent
generations (F2 and F3) without any further immune exposures.
Using the prenatal poly(I:C) administration model in mice, it was
repeatedly shown that some of the behavioral abnormalities are
not only present in the direct descendants of immune-challenged
mothers, but are transmitted to the subsequent generations,91,92
at least when the immune challenge was induced in early/middle
pregnancy (that is, between GD9 and GD12). Interestingly, one
study reported a transgenerational transmission of behavioral
abnormalities mostly via the paternal lineage, which extended to
the third (F3) generation of offspring (Figure 3).92 The paternal
mode of transmission is consistent with other models of early-life
adversities, such as pre- and neonatal stress and prenatal
malnutrition.62–66,70,71 The fact that prenatal immune activation
can cause transgenerational transmission of pathological pheno-
types via the paternal lineage strongly suggests the involvement
of epigenetic modiﬁcations in male gametes, which in turn could
mediate epigenetic inheritance across generations.21,45,63,66 Pre-
natal immune activation thus likely alters epigenetic marks in the
germ line of the direct offspring, which resists erasure and
epigenetic reestablishment during germ cell development.21
It remains to be determined further, however, why early-life
adversities such as maternal infection largely spare the female
germ cells. One possible explanation may relate to the differential
developmental dynamics of male and female gametes. Germ cells
start developing shortly after fertilization and rapidly proliferate
until they migrate to the genital ridge, where sex determination
occurs.21 Once the primordial germ cells are sexually differen-
tiated, oocytes and male germ cells have different developmental
dynamics; following sexual differentiation, the oocyte enters into
meiosis and arrests until puberty, while male germ cells go into
arrest until birth, when they undergo a phase of proliferation and
then complete meiosis during puberty.93
Figure 3. Summary of the transgenerational transmission and modiﬁcation of behavioral deﬁcits induced by prenatal immune activation. The
use of a mouse model of viral-like immune activation, which was induced by maternal treatment with the viral mimetic poly(I:C), led to the
recent discovery of transgenerational effects following prenatal immune activation (for details, see Weber-Stadlbauer et al.92). In this model,
reduced sociability and increased fear-related behavior were similarly present in ﬁrst-generation (F1) and second-generation (F2) offspring of
immune-challenged ancestors. Sensorimotor gating impairments were conﬁned to the direct descendants of infected mothers, whereas
increased behavioral despair emerged as a novel phenotype in the second generation. The transgenerational effects were transmitted via the
paternal lineage (not shown) and were stable until the third generation (F3), demonstrating transgenerational non-genetic inheritance of
pathological traits following prenatal immune activation.
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In addition to its transgenerational effects on behavior, prenatal
exposure to viral-like immune activation in mice was also found to
modify transcriptional activity across generations.92 Using next-
generation mRNA sequencing, it was shown that prenatal poly(I:
C)-induced immune activation caused widespread gene expres-
sion changes in the brains of both the F1 and F2 generations.
Intriguingly, while some transcriptional changes were uniquely
present in either F1 or F2 offspring, others were common to both
generations. Hence, the prenatal infection-induced transgenera-
tional transmission of behavioral abnormalities (Figure 3) is
associated with, and perhaps even mediated by, transgenerational
modiﬁcations of gene expression.
Depending on the timing of the environmental insults or
genetic loci, some of the epigenetic marks may affect only the
germ line while sparing somatic tissues in the ﬁrst generation. This
may explain why certain behavioral deﬁcits emerge as a novel
phenotype only in the second and third generation of infected
ancestors (Figure 3). Future studies are warranted in order to
compare infection-induced epigenetic modiﬁcations in somatic
cells and gametes. Such studies will help to further elucidate the
mechanisms underlying the transgenerational modiﬁcation and
inheritance of brain pathology following prenatal immune
activation.
POTENTIAL MECHANISMS THROUGH WHICH PRENATAL
INFECTION MIGHT INDUCE EPIGENETIC CHANGES (ACROSS
GENERATIONS)
The potential role of cytokines
As mentioned above, epidemiologic studies suggest that the risk
of neurodevelopmental disorders is increased after prenatal
exposure to a variety of viral, bacterial or protozoan pathogens,
including those that are not vertically transmitted to the fetus.
Based on these ﬁndings, it has been proposed that cytokine-
associated inﬂammatory processes may be key in mediating the
negative effects of maternal infection.94 Molecular work in mouse
models of maternal immune activation has provided additional
support for this hypothesis. For example, prenatal administration
with speciﬁc cytokines such as interleukin-6 (IL-6) or IL-17a can
mimic the long-term consequences of prenatal viral-like immune
activation in mice.25,26 Conversely, elimination of these cytokines
from the maternal immune response by genetic interventions or
blocking antibodies attenuates the long-term effects of prenatal
immune challenge on brain and behavior.25,26
Given these ﬁndings, it appears plausible that enhanced
expression of inﬂammatory cytokines may be one of the factors
that can directly alter epigenetic programs in the event of prenatal
infection. In support of this notion, a study by Hodge et al.95
demonstrates that IL-6 increases the expression and biological
activity of DNMT1. Some of the changes in DNMT1 activity may
result from phosphorylation of the enzyme following exposure to
IL-6, and the subsequent activation of downstream signaling
pathways such as the AKT pathway.95 While most of the initial
ﬁndings linking cytokines to epigenetic effects stem from
experiments with cancer cell lines, it is likely that IL-6 regulates
DNMT1 in several distinct cell types, including neurons and other
brain cells. It was shown that IL-6 and DNMT1 can also inﬂuence
cell migration,96 a process which is also essential in neurodevelop-
ment. Recent studies also identiﬁed a direct inﬂuence of IL-17a on
the epigenetic machinery through the modulation of histone
deacetylases (HDACs). More speciﬁcally, IL-17a was shown to
inhibit HDAC activity via the phosphoinositide-3-kinase (PI3K)
pathway.97 Finally, one study found that TNF-alpha increases
histone acetylation activity,98 suggesting that this inﬂammatory
cytokine can act on the epigenetic machinery as well.
Exposure to prenatal inﬂammation stimuli has also been shown
to cause Mecp2 promoter hypomethylation.88 Mecp2 is important
for epigenetic regulation due to its ability to bind to methylated
DNA and to chromatin modifying complexes such as HDACs.
Therefore, Mecp2 is considered both an epigenetic ‘reader’ and a
‘writer’ (for review see Ausio99). Additional research is required,
however, to examine more directly whether the effects of prenatal
immune activation on Mecp2 promoter hypomethylation involves
speciﬁc cytokines or other pathophysiological processes asso-
ciated with inﬂammation.
Taken together, there is initial evidence supporting a role of
cytokines in modulating the epigenetic machinery in the event of
prenatal infection. Hence, increased fetal expression of inﬂamma-
tory cytokines may be one of the upstream factors causing
epigenetic reprogramming and associated neurodevelopmental
changes in offspring of gestationally infected mothers.
The potential role of folic acid
As previously discussed, maternal infection typically leads to
temporary reduced food consumption, thereby reducing nutrient
availability for the developing organism (Figure 1). Besides its
effects on other micronutrients such as zinc and iron, reduced
intake of micronutrients may lead to a transient deﬁciency of folic
acid. Folic acid was shown to play a key role in the modulation of
inﬂammatory responses: supplementation of patients with folic
acid inhibits pro-inﬂammatory responses, such as inhibiting
chemokine secretion and reducing the elevated levels of reactive
oxygen species.100 Vice versa, mouse monocytes, under conditions
of folate deﬁciency, show a 2- to 3-fold increase in the expression
of several inﬂammatory cytokines, such as IL1b, IL-6 and TNFα.101
Folic acid has also long been implicated in neurodevelopmental
processes, as exempliﬁed by the presence of spina biﬁda in
offspring of mothers who were deprived from folic acid during
pregnancy.102 Moreover, imbalances in folate levels during
pregnancy represent an important, epidemiologically valid risk
factor for later psychiatric disease.103 Besides its established etiological
role in neurodevelopmental disorders,104 low levels of folate are
also present in patients diagnosed with schizophrenia.105 There is
a growing body of evidence linking folic acid deﬁciency with
autism as well.106–108 Interestingly, maternal folic acid supple-
mentation has been associated with beneﬁcial effects on
neurodevelopment and autism.103 Moreover, mothers of children
with autism have a signiﬁcantly lower mean folic acid intake
during early pregnancy compared to mothers of children with
autism spectrum disorder.107
Representing one of the major dietary sources for methyl
groups,109 folic acid is likely to have a direct inﬂuence on
epigenetic processes during normal prenatal development.
Indeed, a recent study identiﬁed a striking correlation between
maternal folic acid and methylation status of a variety of genes in
the offspring, some of which are related to neurological functions
and to embryonic development.110 In the pathological context of
maternal infection, decreased availability of folic acid may affect
methylation-related epigenetic processes in the fetus, thereby
contributing to infection-mediated epigenetic programming. Even
though biologically plausible, however, this hypothesis still awaits
direct examination in future studies.
The potential role of the microbiome
The recent years have witnessed an increasing interest in the role
of the microbiome in health and disease. The human body is
composed of a complex ecosystem of microbial cells, approximat-
ing the same number as the number of human cells in the human
body.111 There is a clear symbiotic link between host and microbe,
wherein the microbiota is also key mediating for gene–environ-
ment interactions relevant to various physiological processes.112
Whereas initial studies mainly focused on obesity-related changes
in the microbiome and its contribution to the disease phenotype,
it has recently been shown that the microbiome can also inﬂuence
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behavior and contribute to brain development and function (for
review see Cryan and Dinan113). While the fetal environment was
initially thought to be entirely sterile, recent evidence suggests
that some bacteria are present in the amniotic ﬂuid114 and the
placenta.115 One implication of these new discoveries is that the
microbial composition of the developing offspring may be
sensitive to environmental changes even during prenatal stages
of life. In support of this notion, a recent study in mice demon-
strated that prenatal viral-like immune activation alters the
offspring’s composition of the gut microbiota.116 Notably, some
of the main metabolic products of the gut microbiota are short-
chain fatty acids, including sodium butyrate. Sodium butyrate can
readily cross the blood–brain barrier and has been shown to
modulate the expression of various genes in the prefrontal cortex,
particularly those involved in neuronal excitation or inhibition.117
At the same time, sodium butyrate can interact with the
epigenetic machinery by inhibiting HDACs.118 Therefore, aside
from being a bacterial metabolite and a major source of energy for
intestinal epithelial cells, sodium butyrate represents an efﬁcient
epigenetic regulator. Future studies are warranted in order to
investigate whether infection-induced changes in gut microbiota
may induce downstream changes in sodium butyrate, which in
turn may affect the epigenetic machinery. Such changes would
possibly also affect the fetus’ germ cells, and thereby, they could
also contribute to the transgenerational transmission of behavioral
traits induced by maternal immune activation.
THE INFLUENCE OF THE PRECISE TIMING OF MATERNAL
INFECTION
An important aspect that warrants further investigation relates to
the potential inﬂuence of the precise timing of prenatal immune
activation, both in terms of its effects on the offspring’s
epigenome and on the transgenerational transmission of patho-
logical traits. Exposure to environmental insults during distinct
gestational stages likely affects different neurodevelopmental
events, developing brain regions, and cellular maturational
processes, which in turn might shape the speciﬁcity of long-
term brain dysfunctions in the offspring.34 In support of this
notion, numerous rodent studies highlighted a critical inﬂuence of
the precise timing of prenatal infection with regards to its long-
term brain and behavior consequences in the offspring.119,120
It has long been recognized that epigenetic processes follow
timed developmental patterns during embryogenesis and fetal
development.121,122 It thus follows that maternal immune activa-
tion induces differential epigenetic modiﬁcations in the offspring
depending on the precise timing of exposure. Indeed, a recent
mouse study provided the ﬁrst line of evidence suggesting that
the epigenetic effects of prenatal immune activation are critically
inﬂuenced by the timing of prenatal immune challenge.90 While
immune activation in early and late gestation affected a relatively
small number of common genes, the two prenatal conditions
mostly showed methylation differences in distinct loci.90 More-
over, the differential epigenetic effects of early and late prenatal
immune activation were associated with distinct transcriptional
changes and behavioral abnormalities.90 Against this background,
it appears essential to further explore whether and how timing-
dependent effects are also reﬂected by the nature of the
transgenerational effects induced by prenatal infection.
CONCLUSIONS
The investigation of possible immune mechanisms in neurodeve-
lopmental disorders is a long-standing area of research that
continuously attracts the attention from basic scientists and
clinicians alike. Within this neuroimmune framework of brain
disease, a great deal of interest has been centered on the possible
contribution of infections in prenatal life. The recent outbreak of
Zika virus and its accompanying risk for severe brain anomalies
such as microcephaly123 has moved the risks of prenatal infection
in the spotlight of public attention.
Modeling the consequences of prenatal infection in animals has
led to the new discoveries that this early-life adversity induces
stable epigenetic modiﬁcations in the offspring. There is increas-
ing recognition of and evidence for altered epigenetic program-
ming in the pathogenesis of neurodevelopmental disorders,
including schizophrenia, autism and bipolar disorder.124–127 Against
these backgrounds, the novel ﬁndings of infection-mediated
epigenetic modiﬁcations raise the intriguing possibility that
prenatal exposure to immune challenges may be one of the
environmental factors causing epigenetic abnormalities in these
disabling brain disorders. Since at least some of these epigenetic
modiﬁcations may be modiﬁable throughout life,22,128 these
ﬁndings may help to open new avenues for symptomatic or
even preventive treatments in subjects with prenatal infectious
histories.
The transgenerational transmission and modiﬁcation of brain
pathology following prenatal immune activation highlights a
novel pathological aspect of this early-life adversity in shaping
disease risk across generations. Given that prenatal infection is
implicated in a variety of neurodevelopmental brain disorders,
these new ﬁndings appear relevant to brain disorders indepen-
dently of existing diagnostic classiﬁcations and may help
identifying complex patterns of transgenerational disease trans-
mission beyond genetic inheritance. These discoveries may further
emphasize the importance for global health strategies in focusing
on the development and promoting vaccinations, in particular for
women who are pregnant or those who plan to become pregnant.
Indeed, vaccinations may have the potential to prevent a wide
spectrum of neuropsychiatric and neurological disorders asso-
ciated with prenatal infection, and they may even prevent
possible pathological effects across generations. Unfortunately,
the limited access to vaccines in certain countries, along with the
continuous trend against vaccinations within certain groups of the
society, have led to a resurgence of serious infectious diseases,
including measles, rubella and polio.129 Hence, there are obvious
challenges for future attempts to implement vaccinations as
preventive means against infection-mediated neurodevelopmen-
tal disorders. The continuous implementation and integration of
preclinical studies and human epidemiological research will be
pivotal in overcoming these hurdles and may eventually help
reducing or even preventing the burdens associated with
infection-mediated neurodevelopmental disorders.
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